Le Lézard
Classified in: Covid-19 virus
Subjects: Photo/Multimedia, Conference, Advisory

2nd Annual Gabelli Funds ? Columbia Business School Healthcare Symposium (Virtual)


Join us as we discuss today's pressing healthcare issues.

CO-HOSTS:

Bunny Ellerin Jing He
Director, HPM, Columbia Business School Biotech Analyst, Gabelli Funds
  • MBA, Harvard Business School
  • MBA, Columbia Business School
  • BA, Columbia University
  • MA, Washington University in St. Louis
  • BS, Peking University
Time Agenda
9:00 ? 9:10 AM Welcome
  • Bunny Ellerin, Director, Healthcare and Pharmaceutical Management Program
9:10 ? 10:00 AM Vaccines & Therapeutics to Treat COVID-19
  • David Hering, Regional President, North America, Pfizer Vaccines
  • Dr. Jacqueline Miller, Senior Vice President, Infectious Diseases, Moderna
  • Dr. David Weinreich, Senior Vice President, Global Clinical Development, Regeneron
  • (Moderator) Jing He ?15, Biotech Analyst, Gabelli Funds
10:10 ? 11:00 AM Health Policy & Reimbursement Trends
  • Dr. Deepa Kumaraiah, Senior Vice President, Service Lines and Chief Physician, NYP Medical Groups, New York-Presbyterian
  • Melissa Schulman, Senior Vice President of Government Affairs, CVS Health
  • Professor Michael Sparer, Chair, Health Policy and Management, Columbia University Mailman School of Public Health
  • (Moderator) Jeff Jonas, Portfolio Manager, Gabelli Funds
11:10 ? Noon Healthcare Delivery in a Virtual World
  • Dr. Amy Fahrenkopf, President, HSS Health and Senior Vice President, Hospital for Special Surgery
  • Jason Gorevic, CEO, Teladoc Health
  • Dr. Julie Silverstein, Divisional President, Oak Street Health
  • (Moderator) Kevin Kedra, Healthcare Analyst, G.research

Click Here to Register

Gabelli Funds, LLC is a registered investment adviser with the Securities and Exchange Commission and is a wholly owned subsidiary of GAMCO Investors, Inc. (NYSE: GBL).


These press releases may also interest you

at 06:00
Vaccinologists Keith Klugman and Shabir Madhi Awarded Sabin's Prestigious Gold Medal; Infectious Diseases Epidemiologist Nicole Basta Receives Rising Star Award
The Sabin Vaccine Institute yesterday presented the Albert B. Sabin Gold Medal to physician-researchers Keith Paul Klugman and Shabir Ahmed Madhi, and its Rising Star award to infectious diseases epidemiologist Nicole Elaine Basta at a ceremony in...

at 05:45
Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before April 29, 2024 to Discuss Your Rights - KIND
The Gross Law Firm issues the following notice to shareholders of Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II ....

at 01:20
Biophytis Announces Ratio Change Under its American Depositary Receipt ("ADR") Program
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in thedevelopment oftherapeutics for age-related diseases, today annouces that it will change the ratio...

18 avr 2024
Clinical Trials Matching Software Market Projected to Reach $832.56 million by 2030 - Exclusive Report by 360iResearch
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
Global clinical development on Dengue antiviral candidate will start, Hyundai Bioscience strives to win emergency use authorization
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
SETC-Assistance.org Helps Eligible Self-Employed Workers Receive Up to $32,220 in Tax Credits Through SETC Program
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...

More news about Covid-19 virus...


News published on and distributed by: